Clinical trial

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

NCT02557295

Study summary

ClinicalTrials.gov

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA

Design: OBSERVATIONAL · Status: TERMINATED · Phase: Not specified

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

0 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

No interventions are currently published for this study in CureCurrent. View the original registry record above.

StatusTERMINATED
Study typeOBSERVATIONAL
Start date2013-12-17
PhaseN/A
Advertisement

Interventions

Sponsors & collaborators

Celltrionlead sponsor

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.